Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects
Google DeepMind released AlphaGenome 2, a conditional DNA sequence model that predicts regulatory activity and variant effects per cell type. It is available via the AlphaGenome API for non-commercial research.
Read the full story on MarkTechPost.